Variables | β (95% CI) | Standardized β | p-value | β (95% CI) | Standardized β | p-value | β (95% CI) | Standardized β | p-value |
---|---|---|---|---|---|---|---|---|---|
Follow-up time, months | -1.01 ( -0.09, 0.06) | -0.39 | 0.696 | -0.01 ( -0.09, 0.06) | -0.39 | 0.699 | -0.02 (-0.10,0.07) | -0.36 | 0.715 |
Group status (Intervention group) | 1.47 (-0.15, 3.10) | 1.77 | 0.076 | 1.61 (-0.07, 3.28) | 1.85 | 0.064 | 2.08 (0.34,3.82) | 2.264 | 0.024 |
Group status*timea | -0.13 (-0.02, -0.03)* | -2.46* | 0.014 * | -0.13 (-0.02, -0.03)* | -2.45* | 0.014 * | -0.12* (-0.24, -0.01) | -2.19* | 0.028 |
Age, years | -0.01 (-0.09, 0.08) | -0.12 | 0.902 | -0.03 (-0.12, 0.06) | 0.68 | 0.497 | |||
Male sex | 0.47 (-0.14, 2.08) | 0.56 | 0.574 | 0.15 (-1.55, 1.84) | 0.16 | 0.871 | |||
Education (high vs. low) | 0.62 (-2.56, 1.32) | -0.62 | 0.547 | -055 (-2.59, 1.49) | -0.51 | 0.609 | |||
Baseline proNT pmol/L | 0.02 (0.01, 0.04)* | 0.57* | 0.041 | ||||||
Baseline fasting blood glucose mmol/l | 0.41 (-0.97, 0.07) | 2.05 | 0.571 | ||||||
Baseline ISI | -0.01 (-0.02, 0.01) | -0.47 | 0.637 |